Airsculpt Technologies, Inc.AIRSEarnings & Financial Report
Airsculpt Technologies, Inc. is a medical technology and aesthetic services provider specializing in its proprietary minimally invasive AirSculpt body contouring treatments. The company operates premium clinics across the United States, catering to consumers seeking precise fat removal and body shaping solutions with significantly shorter recovery times than traditional cosmetic procedures.
Revenue
$35.0M
Gross Profit
N/A
Operating Profit
$-9.8M
Net Profit
$-9.5M
Gross Margin
N/A
Operating Margin
-27.9%
Net Margin
-27.2%
YoY Growth
-17.8%
EPS
$-0.15
Financial Flow
Airsculpt Technologies, Inc. Q3 2025 Financial Summary
Airsculpt Technologies, Inc. reported revenue of $35.0M (down 17.8% YoY) for Q3 2025, with a net profit of $-9.5M (down 57.5% YoY) (-27.2% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $35.0M |
|---|---|
| Net Profit | $-9.5M |
| Gross Margin | N/A |
| Operating Margin | -27.9% |
| Report Period | Q3 2025 |
Airsculpt Technologies, Inc. Annual Revenue by Year
Airsculpt Technologies, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $151.8M).
| Year | Annual Revenue |
|---|---|
| 2025 | $151.8M |
| 2024 | $180.3M |
| 2023 | $195.9M |
| 2022 | $168.8M |
Airsculpt Technologies, Inc. Quarterly Revenue & Net Profit History
Airsculpt Technologies, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $33.4M | -14.6% | $1.3M | 3.8% |
| Q3 2025 | $35.0M | -17.8% | $-9.5M | -27.2% |
| Q2 2025 | $44.0M | -13.7% | $-591.0K | -1.3% |
| Q1 2025 | $39.4M | -17.3% | $-2.8M | -7.2% |
| Q4 2024 | $39.2M | -17.7% | $-4.8M | -12.3% |
| Q3 2024 | $42.5M | -9.1% | $-6.0M | -14.2% |
| Q2 2024 | $51.0M | -8.4% | $-3.2M | -6.3% |
| Q1 2024 | $47.6M | +3.9% | $6.0M | 12.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $47.6M | $51.0M | $42.5M | $39.2M | $39.4M | $44.0M | $35.0M | $33.4M |
| YoY Growth | 3.9% | -8.4% | -9.1% | -17.7% | -17.3% | -13.7% | -17.8% | -14.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $202.7M | $210.1M | $208.2M | $212.8M | $203.3M | $198.4M | $185.9M | $187.3M |
| Liabilities | $119.2M | $125.1M | $125.7M | $134.6M | $125.9M | $107.2M | $103.8M | $99.6M |
| Equity | $83.5M | $85.0M | $82.5M | $78.2M | $77.3M | $91.2M | $82.1M | $87.7M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.4M | $3.4M | $1.8M | $2.7M | $868000 | $5.0M | $-225000 | $-2.5M |